New developments in LC-MS/MS: An interview with Thermo Fisher's Dr. Edward Goucher

[ruzicema]

Thermo Fisher Scientific's Transcend™ DSX-1 System with TSQ Altis™ Plus Triple Quadrupole Mass Spectrometer

Clinical Laboratory International (CLI) spoke with Dr. Edward Goucher, Senior Manager of Business Development, at Thermo Fisher Scientific, to discuss new developments in the world of clinical mass spectrometry. Pressing questions such as "What are Thermo Fisher’s main goals for platform and workflow innovations?" and "LC-MS/MS is a gold standard technology for many assays – what are the challenges in this area and what recent developments has Thermo Fisher made to help overcome them?" were posed. Dr. Goucher revealed the many ways in which Thermo Fisher has supported clinical labs in the ever changing and at times unpredictable clinical research and diagnostic landscape. He then delved into what Thermo Fisher is doing to combat future challenges. Click here to read more. 

Thermo Fisher Scientific's Orbitrap Exploris™ 120 Mass Spectrometer

For additional information on the clinical IVD market, check out this recent article from the American Association for Clinical Chemistry (AACC)!